Cross-source evidence timeline

Petrelintide research timeline

Follow 6 selected, directly cited source records from March 23, 2026 through August 7, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

6Selected records
1Source years
2Evidence lanes
August 7, 2026Latest source date

Source year

2026

6 records
Clinical trials · 5Literature metadata · 1
  1. Clinical trials

    ClinicalTrials.gov record NCT07589686

    PeptideScanner retained ClinicalTrials.gov record NCT07589686 at 2026-08-13T05:52:27.014Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was petrelintide.

  2. Literature metadata

    PubMed record PMID 42017294

    PeptideScanner retained PubMed bibliographic metadata for PMID 42017294 at 2026-08-10T18:13:48.775Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-04-22. PeptideScanner associated this retained record with the identity slug petrelintide. These dates describe PubMed metadata history, not the article's original publication date.

  3. Clinical trials

    Petrelintide combination study record posted

    ClinicalTrials.gov lists a Petrelintide study that is not yet recruiting sponsored by Hoffmann-La Roche.

  4. Clinical trials

    ClinicalTrials.gov record NCT07682818

    PeptideScanner retained ClinicalTrials.gov record NCT07682818 at 2026-08-10T18:10:03.938Z. Its registry update date was 2026-07-06, and PeptideScanner's reviewed identity mapping was petrelintide.

  5. Clinical trials

    ClinicalTrials.gov record NCT07338214

    PeptideScanner retained ClinicalTrials.gov record NCT07338214 at 2026-07-30T16:20:49.304Z. Its registry update date was 2026-04-08, and PeptideScanner's reviewed identity mapping was petrelintide.

  6. Clinical trials

    ClinicalTrials.gov record NCT06662539

    PeptideScanner retained ClinicalTrials.gov record NCT06662539 at 2026-07-30T16:22:22.334Z. Its registry update date was 2026-03-23, and PeptideScanner's reviewed identity mapping was petrelintide.